Respiratorius AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Apr '22 Apr 30, 2022	Dec '21 Dec 31, 2021
Net Income	-7.12	-7.57	-7.83	-12.87	-12.69	-9.64
Depreciation & Amortization	0.43	0.41	0.35	0.56	2.99	1.19
Other Amortization	2.99	2.99	2.94	1.76	1.76	1.84
Other Operating Activities	0.42	0	-	-	0	-
Change in Accounts Receivable	-0.02	-0.02	0.44	-0.23	0.87	0.15
Change in Other Net Operating Assets	0.45	-0.4	-0.16	-15.76	20.22	3.56
Operating Cash Flow	-2.86	-4.6	-4.26	-26.53	13.15	-2.9
Sale (Purchase) of Intangibles	-0.86	-0.86	-1.35	-11.18	-44.17	-18.33
Investing Cash Flow	-4.57	-0.86	-1.35	-11.18	-44.17	-18.33
Issuance of Common Stock	11.16	11.16	-	-	119.92	37.17
Other Financing Activities	-3.93	-	-	-36.95	-	-
Financing Cash Flow	7.23	11.16	-	-36.95	119.92	37.17
Net Cash Flow	-0.21	5.7	-5.61	-74.66	88.91	15.95
Levered Free Cash Flow	7.5	-2.63	-2.68	-20.47	-	-17.61
Unlevered Free Cash Flow	7.53	-2.59	-2.67	-20.47	-	-17.56
Change in Working Capital	0.43	-0.43	0.28	-15.98	21.09	3.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.